In an all-hands company meeting broadcast on X, Tesla Chief Executive Elon Musk urged employees to hold on to their shares, ...

Wedbush analyst Robert Driscoll maintained a Buy rating on Monte Rosa Therapeutics (GLUE – Research Report) today and set a price target of ...

In a report released today, Nick Setyan from Wedbush maintained a Hold rating on Lennar (LEN – Research Report), with a price target of ...

Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn the EV maker's ...

Zenas BioPharma (ZBIO) stock rises as Wedbush issues a bullish recommendation based on the company's lead asset obexelimab. Read more here.

The dominant EV maker in the nation is now a partisan lightning rod that’s losing value fast. But a weakened giant can cause harm regardless of politics.

Fintel reports that on March 20, 2025, Wedbush initiated coverage of Zenas BioPharma (NasdaqGS:ZBIO) with a Outperform ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) – Wedbush decreased their Q1 2025 ... Finally, SG Americas Securities LLC lifted its stake in shares of Mersana Therapeutics by 28.7 ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla is ...

Investing.com-- Analysts at Wedbush Securities have added Tesla Inc (NASDAQ:TSLA) to their "Best Ideas List", citing expectations for a major innovation cycle ahead. Wedbush maintained an “Outperform” ...